264 related articles for article (PubMed ID: 18220661)
1. Diabetic vasculopathy and the lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1).
Renie G; Maingrette F; Li L
Curr Diabetes Rev; 2007 May; 3(2):103-10. PubMed ID: 18220661
[TBL] [Abstract][Full Text] [Related]
2. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), a relevant target for diabetic vasculopathy?
Renier G
Cardiovasc Hematol Disord Drug Targets; 2008 Sep; 8(3):203-11. PubMed ID: 18781933
[TBL] [Abstract][Full Text] [Related]
3. LOX-1-Mediated Effects on Vascular Cells in Atherosclerosis.
Chistiakov DA; Orekhov AN; Bobryshev YV
Cell Physiol Biochem; 2016; 38(5):1851-9. PubMed ID: 27160316
[TBL] [Abstract][Full Text] [Related]
4. Galectin-3 aggravates ox-LDL-induced endothelial dysfunction through LOX-1 mediated signaling pathway.
Ou HC; Chou WC; Hung CH; Chu PM; Hsieh PL; Chan SH; Tsai KL
Environ Toxicol; 2019 Jul; 34(7):825-835. PubMed ID: 30963716
[TBL] [Abstract][Full Text] [Related]
5. Arsenic augments the uptake of oxidized LDL by upregulating the expression of lectin-like oxidized LDL receptor in mouse aortic endothelial cells.
Hossain E; Ota A; Karnan S; Damdindorj L; Takahashi M; Konishi Y; Konishi H; Hosokawa Y
Toxicol Appl Pharmacol; 2013 Dec; 273(3):651-8. PubMed ID: 24145059
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy in apolipoprotein E-null mice.
Inoue K; Arai Y; Kurihara H; Kita T; Sawamura T
Circ Res; 2005 Jul; 97(2):176-84. PubMed ID: 15961718
[TBL] [Abstract][Full Text] [Related]
7. Upregulated LOX-1 Receptor: Key Player of the Pathogenesis of Atherosclerosis.
Singh S; Gautam AS
Curr Atheroscler Rep; 2019 Jul; 21(10):38. PubMed ID: 31350594
[TBL] [Abstract][Full Text] [Related]
8. [Effects of oxidized low-density lipoprotein on endothelial progenitor cells survival and activity mediated by lectin-like oxidized low density lipoprotein receptor].
Ma FX; Ren Q; Han ZC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Jun; 29(3):336-41. PubMed ID: 17633458
[TBL] [Abstract][Full Text] [Related]
9. LOX-1, OxLDL, and atherosclerosis.
Pirillo A; Norata GD; Catapano AL
Mediators Inflamm; 2013; 2013():152786. PubMed ID: 23935243
[TBL] [Abstract][Full Text] [Related]
10. LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis.
Chen M; Masaki T; Sawamura T
Pharmacol Ther; 2002 Jul; 95(1):89-100. PubMed ID: 12163130
[TBL] [Abstract][Full Text] [Related]
11. LOX-1-dependent transcriptional regulation in response to oxidized LDL treatment of human aortic endothelial cells.
Mattaliano MD; Huard C; Cao W; Hill AA; Zhong W; Martinez RV; Harnish DC; Paulsen JE; Shih HH
Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1329-37. PubMed ID: 19279231
[TBL] [Abstract][Full Text] [Related]
12. [LOX-1 receptor as a novel target in endothelial dysfunction and atherosclerosis].
Morawietz H
Dtsch Med Wochenschr; 2010 Feb; 135(7):308-12. PubMed ID: 20146162
[TBL] [Abstract][Full Text] [Related]
13. Lectin-like oxidized low-density lipoprotein receptor (LOX-1) in sickle cell disease vasculopathy.
Chen M; Qiu H; Lin X; Nam D; Ogbu-Nwobodo L; Archibald H; Joslin A; Wun T; Sawamura T; Green R
Blood Cells Mol Dis; 2016 Sep; 60():44-8. PubMed ID: 27519944
[TBL] [Abstract][Full Text] [Related]
14. Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) in atherogenesis: a brief review.
Reiss AB; Anwar K; Wirkowski P
Curr Med Chem; 2009; 16(21):2641-52. PubMed ID: 19601801
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide augments the uptake of oxidized LDL by up-regulating lectin-like oxidized LDL receptor-1 in macrophages.
Hossain E; Ota A; Karnan S; Takahashi M; Mannan SB; Konishi H; Hosokawa Y
Mol Cell Biochem; 2015 Feb; 400(1-2):29-40. PubMed ID: 25348362
[TBL] [Abstract][Full Text] [Related]
16. Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells.
Lee WJ; Ou HC; Hsu WC; Chou MM; Tseng JJ; Hsu SL; Tsai KL; Sheu WH
J Vasc Surg; 2010 Nov; 52(5):1290-300. PubMed ID: 20692795
[TBL] [Abstract][Full Text] [Related]
17. Induction of the oxLDL receptor LOX-1 by endothelin-1 in human endothelial cells.
Morawietz H; Duerrschmidt N; Niemann B; Galle J; Sawamura T; Holtz J
Biochem Biophys Res Commun; 2001 Jun; 284(4):961-5. PubMed ID: 11409887
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in endothelial cells by nitric oxide deficiency.
Smirnova IV; Sawamura T; Goligorsky MS
Am J Physiol Renal Physiol; 2004 Jul; 287(1):F25-32. PubMed ID: 15010359
[TBL] [Abstract][Full Text] [Related]
19. Palmitic acid enhances lectin-like oxidized LDL receptor (LOX-1) expression and promotes uptake of oxidized LDL in macrophage cells.
Ishiyama J; Taguchi R; Yamamoto A; Murakami K
Atherosclerosis; 2010 Mar; 209(1):118-24. PubMed ID: 19782984
[TBL] [Abstract][Full Text] [Related]
20. The oral anti-diabetic agent, gliclazide, inhibits oxidized LDL-mediated LOX-1 expression, metalloproteinase-9 secretion and apoptosis in human aortic endothelial cells.
Li L; Renier G
Atherosclerosis; 2009 May; 204(1):40-6. PubMed ID: 18801483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
